Evidence map›Paper›PMID 27248151›Full record

ArticlePloS one2016

Low Serum Creatine Kinase Level Predicts Mortality in Patients with a Chronic Kidney Disease.

Adrien Flahault, Marie Metzger, Jean-François Chassé, Jean-Philippe Haymann, Jean-Jacques Boffa, Martin Flamant, François Vrtovsnik, Pascal Houillier, Bénédicte Stengel, Eric Thervet and 2 more

Abstract read
In one paragraph

Article in PloS one, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Observational
  7. Article
  8. Article
  9. Creatine Kinase and Mortality in Peritoneal Dialysis.Frontiers in cardiovascular medicine · 2022
    Article
  10. Observational
  11. Article
  12. Observational
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Adrien FlahaultService de néphrologie, Hôpital Européen Georges Pompidou, Assistance Publique Hôpitaux de Paris (AP-HP), Paris, France.ORCID http://orcid.org/0000-0003-4632-6332
Marie MetzgerINSERM UMRS-1018, CESP Team 5 (Renal and Cardiovascular Epidemiology), Villejuif, France.
Jean-François ChasséParis Descartes University, Paris, France, Sorbonne Paris Cité, Paris, France.
Jean-Philippe HaymannUniversité Pierre et Marie Curie, INSERM U702, Paris, France.
Jean-Jacques BoffaHôpital Tenon, AP-HP, Service de Néphrologie, Paris, France.
Martin FlamantHôpital Bichat, AP-HP, Service de Physiologie, Paris, France.
François VrtovsnikHôpital Bichat, AP-HP, Service de Néphrologie, Paris, France.
Pascal HouillierHôpital Européen Georges Pompidou, AP-HP, Service d'Explorations Fonctionnelles, Paris, France.
Bénédicte StengelINSERM UMRS-1018, CESP Team 5 (Renal and Cardiovascular Epidemiology), Villejuif, France.
Eric ThervetService de néphrologie, Hôpital Européen Georges Pompidou, Assistance Publique Hôpitaux de Paris (AP-HP), Paris, France.
Nicolas PalletParis Descartes University, Paris, France, Sorbonne Paris Cité, Paris, France.
NephroTest study group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSerum creatine kinase (sCK) reflects CK activity from striated skeletal muscle. Muscle wasting is a risk factor for mortality in patients with chronic kidney disease (CKD). The aim of this study is to evaluate whether sCK is a predictor of mortality and end-stage renal disease (ESRD) in a CKD population.

methodsWe included 1801 non-dialysis-dependent CKD patients from the NephroTest cohort. We used time-fixed and time-dependent cause-specific Cox models to estimate hazard ratios (HRs) for the risk of death and for the risk of ESRD associated with gender-specific sCK tertiles.

resultsHigher sCK level at baseline was associated with a lower age, a higher body mass index, and a higher level of 24 h urinary creatinine excretion, serum albumin and prealbumin (p<0.001). Men, patients of sub-Saharan ancestry, smokers and statin users also experienced a higher level of sCK. In a time-fixed Cox survival model (median follow-up 6.0 years), the lowest gender-specific sCK tertile was associated with a higher risk of death before and after adjustment for confounders (Crude model: hazard ratio (HR) 1.77 (95% CI: 1.34-2.32) compared to the highest tertile; fully-adjusted model: HR 1.37 (95% CI: 1.02-1.86)). Similar results were obtained with a time-dependent Cox model. The sCK level was not associated with the risk of ESRD.

conclusionA low level of sCK is associated with an increased risk of death in a CKD population. sCK levels might reflect muscle mass and nutritional status.

Indexed as

AgedCohort StudiesCreatine KinaseFemaleHumansKidney Failure, ChronicMaleMiddle AgedProportional Hazards ModelsCreatine Kinase

Identifiers

PMID27248151
PMCPMC4889148

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.